Tokyo based TANAKA Kikinzoku Kogyo K.K. has made an equity contribution to the medical venture capital fund 'Diamond Medino Capital (DMC) No. 1 Investment Limited Partnership'. Through this equity contribution, TANAKA Kikinzoku Kogyo will contribute toward technological development in Japan's domestic medical and healthcare industry.

DMC fund is the first in Japan to be led by active parties in the field of medicine with the principle to establish a medical venture ecosystem originating from Japan. Founded by Professor Terumitsu Hasebe (Professor, Faculty of Medicine, School of Medicine, Tokai University), the initiative is the first of its kind in Japan to be established by expertise in the medical field.

The fund will support Japan's new and current medical ventures by closely assisting them in terms of human resources, capital, management, pharmaceutical, patent, exit, and other strategies.

Through equity contribution to this fund, TANAKA Kikinzoku Kogyo also expects to strengthen relationships with Japan's medical ventures and expand future medical business, such as the development of new products and technologies, in the healthcare industry.